E I Mohamed1, M A Mohamed2, M H Moustafa1, S M Abdel-Mageed3, A M Moro4, A I Baess5, S M El-Kholy1. 1. Department of Medical Biophysics. 2. Department of Chemical Pathology, Medical Research Institute. 3. Physics Department, Faculty of Science, Alexandria University, Alexandria. 4. Biomedical Equipment and Systems Department, Faculty of Applied Medical Sciences, 6 October University, Cairo. 5. Chest Diseases Department, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Abstract
OBJECTIVE: To apply an e-nose system for monitoring headspace volatiles in biological samples from Egyptian patients with active pulmonary tuberculosis (TB) and healthy controls (HCs) and compare them with standard sputum analysis. DESIGN: The study population comprised 260 (140 males, 120 females) newly diagnosed TB patients and 240 (120 males, 120 females) HCs matched by age and socio-economic level admitted to hospitals specialising in chest diseases in Alexandria, Behera, Giza and Damietta Governorates, Egypt. Participants provided a history of TB and underwent clinical examinations, chest X-ray, and microbiological and e-nose analyses. Biological samples (blood, breath, sputum and urine) were collected. RESULTS AND CONCLUSION: Being a confirmed TB patient was directly proportional to e-nose 10-sensor responses. Principal component analysis clusters showed a clear distinction between TB and HC groups, with variances of 93%, 85%, 75% and 95% for blood, breath, sputum and urine samples, respectively. Overall accuracy, sensitivity and specificity of the artificial neural network (ANN) analysis for classifying samples were >99%. The e-nose successfully distinguished TB patients from HC participants for all measured biological samples with great precision. With urine samples gaining broader acceptance for clinical diagnosis, an e-nose-based ANN can be a very useful tool for low-cost mass screening and early detection of TB patients in developing countries.
OBJECTIVE: To apply an e-nose system for monitoring headspace volatiles in biological samples from Egyptian patients with active pulmonary tuberculosis (TB) and healthy controls (HCs) and compare them with standard sputum analysis. DESIGN: The study population comprised 260 (140 males, 120 females) newly diagnosed TB patients and 240 (120 males, 120 females) HCs matched by age and socio-economic level admitted to hospitals specialising in chest diseases in Alexandria, Behera, Giza and Damietta Governorates, Egypt. Participants provided a history of TB and underwent clinical examinations, chest X-ray, and microbiological and e-nose analyses. Biological samples (blood, breath, sputum and urine) were collected. RESULTS AND CONCLUSION: Being a confirmed TB patient was directly proportional to e-nose 10-sensor responses. Principal component analysis clusters showed a clear distinction between TB and HC groups, with variances of 93%, 85%, 75% and 95% for blood, breath, sputum and urine samples, respectively. Overall accuracy, sensitivity and specificity of the artificial neural network (ANN) analysis for classifying samples were >99%. The e-nose successfully distinguished TB patients from HC participants for all measured biological samples with great precision. With urine samples gaining broader acceptance for clinical diagnosis, an e-nose-based ANN can be a very useful tool for low-cost mass screening and early detection of TB patients in developing countries.
Authors: Antonia M I Saktiawati; Ymkje Stienstra; Yanri W Subronto; Ning Rintiswati; Jan-Willem Gerritsen; Henny Oord; Onno W Akkerman; Tjip S van der Werf Journal: PLoS One Date: 2019-06-13 Impact factor: 3.240
Authors: Antonia M I Saktiawati; David Dwi Putera; Althaf Setyawan; Yodi Mahendradhata; Tjip S van der Werf Journal: EBioMedicine Date: 2019-08-08 Impact factor: 8.143
Authors: Lili Kang; Lesley Workman; Heather J Zar; Jane E Hill; Carly A Bobak; Lindy Bateman; Mohammad S Khan; Margaretha Prins; Lloyd May; Flavio A Franchina; Cynthia Baard; Mark P Nicol Journal: Sci Rep Date: 2021-02-01 Impact factor: 4.379
Authors: I G van der Sar; N Wijbenga; M E Hellemons; C C Moor; G Nakshbandi; J G J V Aerts; O C Manintveld; M S Wijsenbeek Journal: Respir Res Date: 2021-09-17